Advertisement
Advertisement

EPRX

EPRX logo

Eupraxia Pharmaceuticals Inc. Common Stock

7.55
USD
Sponsored
-0.06
-0.79%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

7.71

+0.16
+2.05%

Eupraxia Pharmaceuticals Inc. Common Stock Profile

About

Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company. It focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Th company's lead product candidate includes EP-104IAR, for the treatment of pain due to osteoarthritis of the knee. Eupraxia Pharmaceuticals Inc. is based in VICTORIA, BC.

Info & Links

CEO

James A. Helliwell

Headquarters

201-2067 CADBORO BAY RD.
VICTORIA, A1 V8R 5G4, CANADA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.eupraxiapharma.com/home/default.aspx

Auditor

KPMG LLP

Share holders

--

Employees

49

Eupraxia Pharmaceuticals Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

473.88M

Enterprise Value

393.47M

Enterprise Value/EBITDA(ttm)

-10.30

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.02

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-167.68%

Return on Invested Capital(ttm)

-94.65%

Return on Assets(ttm)

-66.72%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-38.20M

Net Income Available to Common(ttm)

-41.11M

Diluted EPS(ttm)

-1.03

Share Statistics

Beta (5Y Monthly)

1.55

52-Week Change

95.09%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

51.94M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

80.56M

Total Cash Per Share(mrq)

1.55

Total Debt(mrq)

154.40K

Total Debt/Equity(mrq)

0.19%

Current Ratio(mrq)

15.12%

Quick Ratio(mrq)

15.12%

Book Value Per Share(mrq)

1.55

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.71

Free Cash Flow(ytd)

-29.14M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement